Richard Muwonge Selected Research

Lugol's solution (Lugol's iodine)

9/2012	Accuracy of concurrent visual and cytology screening in detecting cervical cancer precursors in rural India.
10/2010	Visual screening for early detection of cervical neoplasia in Angola.
5/2010	Evaluation of cervical visual inspection screening in Dar es Salaam, Tanzania.
3/2010	Cytology versus HPV testing for the detection of high-grade cervical lesions in women found positive on visual inspection in Mumbai, India.
1/2007	Assessing the gain in diagnostic performance when two visual inspection methods are combined for cervical cancer prevention.
3/2005	Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard Muwonge Research Topics

Disease

22	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2022 - 01/2003
12	Neoplasms (Cancer) 10/2021 - 01/2003
9	Uterine Cervical Dysplasia 10/2020 - 01/2007
5	Infections 11/2021 - 01/2016
4	Persistent Infection 11/2021 - 01/2016
4	Papillomavirus Infections 01/2018 - 01/2016
2	Squamous Intraepithelial Lesions 10/2020 - 03/2005
2	Pain (Aches) 05/2020 - 01/2020
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2015 - 07/2006
1	Chronic Pain 12/2021
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Abdominal Pain (Pain, Abdominal) 02/2021
1	Mouth Neoplasms (Oral Cancer) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Coinfection 01/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2014
1	Carcinoma (Carcinomatosis) 02/2014
1	Malaria 07/2006
1	Exanthema (Rash) 07/2006
1	Pruritus (Itching) 07/2006
1	Opportunistic Infections (Opportunistic Infection) 07/2006
1	Pneumonia (Pneumonitis) 05/2004

Drug/Important Bio-Agent (IBA)

21	Acetic Acid (Vinegar)FDA LinkGeneric 10/2016 - 01/2003
6	VaccinesIBA 11/2021 - 05/2004
6	Lugol's solution (Lugol's iodine)IBA 09/2012 - 03/2005
4	Papillomavirus Vaccines (HPV Vaccines)IBA 11/2021 - 01/2016
2	Indicators and Reagents (Reagents)IBA 12/2021 - 10/2021
2	Biomarkers (Surrogate Marker)IBA 10/2020 - 07/2020
1	Dihydrotachysterol (AT 10)IBA 11/2021
1	cyclo(Arg-Pro) (CI 4)IBA 01/2020
1	Messenger RNA (mRNA)IBA 12/2019
1	DNA (Deoxyribonucleic Acid)IBA 12/2019
1	SugarsIBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	Neutralizing AntibodiesIBA 01/2019
1	Progesterone FDA LinkGeneric 12/2016
1	ORALIT (ORS)IBA 12/2016
1	Estrogens (Estrogen)FDA Link 12/2016
1	Combined VaccinesIBA 01/2016
1	ElementsIBA 01/2016
1	Immunologic Factors (Immunomodulators)IBA 04/2014
1	Biological ProductsIBA 10/2013
1	Pharmaceutical PreparationsIBA 07/2006
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 07/2006

Therapy/Procedure

5	Cryotherapy (Therapy, Cold) 05/2020 - 03/2013
4	Aftercare (After-Treatment) 02/2021 - 05/2009
1	Continuity of Patient Care 05/2022
1	Secondary Prevention 01/2019
1	Conservative Treatment 02/2017
1	Electrocoagulation (Electrocautery) 06/2016
1	Drug Therapy (Chemotherapy) 02/2014
1	Mastectomy (Mammectomy) 01/2012
1	Contraception (Birth Control) 01/2003